Prostate cancer: where are we and where are we going?
- 1 March 1997
- journal article
- review article
- Published by Wiley in British Journal of Urology
- Vol. 79 (S1), 2-7
- https://doi.org/10.1111/j.1464-410x.1997.tb00794.x
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- KAI1 , a Metastasis Suppressor Gene for Prostate Cancer on Human Chromosome 11p11.2Science, 1995
- Inhibition of tumor angiogenesis and the therapeutic ability of linomide against rat prostatic cancersThe Prostate, 1995
- Proliferation‐dependent vs. independent programmed cell death of prostatic cancer cells involves distinct gene regulationThe Prostate, 1994
- Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cellsThe Prostate, 1994
- Interleukin‐2 transfected prostate cancer cells generate a local antitumor effect in vivoThe Prostate, 1994
- Derivatives of thapsigargin as probes of its binding site on endoplasmic reticulum Ca2+ ATPaseFEBS Letters, 1993
- The natural history of adenocarcinoma of the prostateJournal of Cellular Biochemistry, 1992
- Enzymatic activity of prostate‐specific antigen and its reactions with extracellular serine proteinase inhibitorsEuropean Journal of Biochemistry, 1990
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989